From lab to life

Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “Rusnano”, a $7 billion Russian Federation fund, in collaboration with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia and Cleveland Clinic Foundation. Panacela Labs is 54.6% owned by Cleveland BioLabs.